Results 51 to 60 of about 5,385 (167)

Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study

Colorectal Disease, Volume 27, Issue 10, October 2025.
Abstract Aim Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for peritoneal metastases (PM) of colorectal or appendiceal origin. Rectal anastomotic leakage (RAL) or rectal stump blow‐out is a serious complication following rectal resection after CRS‐HIPEC. This study aimed to compare outcomes
Lana Ghanipour, Lana Othman Mahmmud, Peter Cashin, Gabriella Jansson Palmer, Mirna Abraham‐Nordling   +4 more
wiley   +1 more source

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case series

Asian Journal of Medical Sciences
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment for advanced abdominopelvic malignancies with peritoneal carcinomatosis. Cytoreductive surgery (CRS) with HIPEC offers hope by increasing the survival rates of these cancers ...
Aswini Lakshminarasimhan , Rajasekar Radhakrishnan , Gowtham Selvarasu   +2 more
doaj   +1 more source

Closed‐Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery

International Wound Journal, Volume 22, Issue 10, October 2025.
ABSTRACT Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed‐incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications.
Josep M. Badia, Inés Rubio‐Pérez, Carlos Morales‐Pérez, José Bueno‐Lledó, Laura M. Rodríguez‐Lorenzo, Joan Sancho, Oliver Marín‐Peña, Susana López, Jaume Masià, José M. Balibrea   +9 more
wiley   +1 more source

Prophylactic hyperthermic intraperitoneal chemotherapy is associated with improved disease-free survival in pathologic T4 colorectal cancer: a propensity score–matched cohort study

World Journal of Surgical Oncology
Background Pathologic T4 colorectal cancer (CRC) carries a high risk of peritoneal recurrence despite curative resection. Early postoperative hyperthermic intraperitoneal chemotherapy (HIPEC) may enhance intraperitoneal cytotoxic exposure and improve ...
Rongpeng Chen, Sihan Hu, Zhicheng Feng, Feng Xiao, Guoqiang Wang   +4 more
doaj   +1 more source

Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer

CA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 436-460, September/October 2025.
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki, Britta Lange, Kevin M. Elias, Marcia C. Haigis, Sylvia Mechsner, Ioana Elena Braicu, Jalid Sehouli   +6 more
wiley   +1 more source

Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study

Cancer Medicine, Volume 14, Issue 18, September 2025.
ABSTRACT Background Cross‐resistance is observed between platinum and Poly (ADP‐ribose) polymerase inhibitors (PARPi). We aim to propose the definition of PARPi resistance and demonstrate the best therapeutic strategy for patients with PARPi resistance.
Rui Gou, Qi Xie, Haishan Ren, Hui Zhang, Tingting Wang, Ziyu Li, Zhenning Li, Ruichen Wang, Yingchao Yang, Xiaoyan Shen, Yi Li, Yue Wang, Lihui Wei, Xiaoping Li   +13 more
wiley   +1 more source

HIPEC Ca Ορθού

, 2021
Globally colorectal cancer is the third most common cancer and ranks as the fourth most common cancer related mortality. The American Cancer Society (ACS) estimates that 97,220 new cases of colon cancer and 43,030 new cases of rectal cancer will occur in 2018; 25,920 cases of rectal cancer are expected in men and 17,110 in women accordingly ...
openaire   +1 more source

Adjuvant HIPEC for gastric cancer [PDF]

Journal of Gastrointestinal Oncology, 2021
Paul H, Sugarbaker, Kurt, Van der Speeten   +1 more
openaire   +2 more sources

Heating technology for malignant tumors: a review

International Journal of Hyperthermia, 2020
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia, i.e., heating to 39–45 °C to induce sensitization to radiotherapy and chemotherapy, and thermal ablation, where temperatures beyond 50 °C destroy tumor cells ...
H. Petra Kok, Erik N. K. Cressman, Wim Ceelen, Christopher L. Brace, Robert Ivkov, Holger Grüll, Gail ter Haar, Peter Wust, Johannes Crezee   +8 more
doaj   +1 more source

HIPEC ir citoredukcinių operacijų patirtis

Sveikatos mokslai, 2013
The aim of the study is to summarize our first experience in cytoreductive surgery(CRS) combined with intraoperative intraperitoneal chemotherapy (HIPEC) in Klaipeda University hospital. Patients and methods. A retrospective analysis of our first 10 patients who were treated with cytoreductive surgery combined with hyperthermic intraperitoneal ...
Vitalijus Eismontas, Vaidotas Turskis, Alvydas Česas, Algirdas Šlepavičius   +3 more
openaire   +1 more source